sthrn labs is launching soon. Browse the catalog, review our COAs, and inquire to order.
KPV
KPV is a tripeptide derived from alpha-MSH studied for its potential anti-inflammatory properties in preclinical research models. Supplied as a lyophilized powder for research use only.
Compound information
What is KPV?
Stability information
Research highlights
NF-κB pathway inhibition
Research on this α-MSH-derived tripeptide's suppression of inflammatory signaling.
PepT1-mediated transport
Studies examining cellular uptake via the PepT1 di/tripeptide transporter.
Intestinal inflammation models
Investigating anti-inflammatory effects in IBD and colitis models.
Epithelial barrier research
Mechanistic work on epithelial integrity and pro-inflammatory cytokine reduction.
Sources & references
PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation
Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease
Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides
Orally targeted delivery of tripeptide KPV via hyaluronic acid–functionalized nanoparticles efficiently alleviates ulcerative colitis
All citations link directly to primary literature. sthrn labs does not reproduce, excerpt, or summarize article content.
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.
